Skip to content

Review, 2015

Does a progesterone metabolite called allopregnanolone cause mood problems in PMDD?

In some women with PMDD, the progesterone metabolite allopregnanolone is linked to negative mood during the luteal phase, despite being expected to be calming. A preliminary clinical trial of a blocking agent called isoallopregnanolone showed good effects in treating PMDD symptoms.

Moderate study design Research review on women with PMDD and allopregnanolone

What they did

A review of research on allopregnanolone, a metabolite of progesterone that affects GABA receptors in the brain. The review examined how allopregnanolone levels relate to mood changes in women with PMDD and discussed a preliminary clinical trial testing an antagonist to allopregnanolone.

What they found

In women with PMDD, increased negative mood relates to allopregnanolone during the luteal phase of the menstrual cycle. This is paradoxical because GABA receptor modulators are expected to have calming and anxiety-reducing effects. The severity of mood symptoms follows an inverted U-shaped curve with allopregnanolone at endogenous luteal-phase levels. Isoallopregnanolone, an antagonist to allopregnanolone, was used in a preliminary clinical trial and showed good effects in ameliorating PMDD symptoms.

What it means for you

Allopregnanolone may play a role in mood changes in PMDD through an unexpected mechanism. Blocking this hormone might help some women with PMDD. The main limitation is that this review discusses only preliminary evidence and a preliminary clinical trial, with no final results or effectiveness data presented.

About the study

Original title
GABAA Receptor-Modulating Steroids in Relation to Women's Behavioral Health
Authors
Bäckström T, Bixo M, Strömberg J
Journal
Current psychiatry reports
Year
2015
Study design
Review
What was tested
Isoallopregnanolone antagonist (preliminary trial only)

Topics